The Initiative for Medicines, Access, and Knowledge (I-MAK) is a U.S.-based nonprofit advocacy organization focused on making the medicines system more just and equitable by improving access to affordable medicines and challenging patent practices that can block competition.
Drug pricing and affordability, patent and intellectual property reform, access to medicines, public health policy, transparency in pharmaceutical patenting, and consumer/patient protections in health care markets.
Primarily supported by foundations and philanthropists; it states that it does not accept funding from branded or generic pharmaceutical companies.
Works with patients, public health professionals, policymakers, scientists, economists, patent offices, and community organizations; has been associated with global health and access-to-medicines partners such as the World Health Organization, Unitaid, GAVI, and the Clinton Health Access Initiative.
501(c)(3) nonprofit organization
